Julie Yang
Psychiatric/Mental Health · Compton, CANPI 1861825960
Payments from drug & device makers
Across 283 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$766
- Teva Pharmaceuticals USA, Inc.$748
- Otsuka America Pharmaceutical, Inc.$522
- Neurocrine Biosciences, Inc.$518
- Johnson & Johnson$450
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,088100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 45 | $1,102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $766 |
| Teva Pharmaceuticals USA, Inc. | 45 | $748 |
| Otsuka America Pharmaceutical, Inc. | 26 | $522 |
| Neurocrine Biosciences, Inc. | 13 | $518 |
| Johnson & Johnson | 24 | $450 |
| Sunovion Pharmaceuticals Inc. | 31 | $424 |
| AbbVie | 13 | $395 |
| Lundbeck LLC | 14 | $257 |
| Axsome Therapeutics, Inc. | 6 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $125 |
| Novo Nordisk | 1 | $119 |
| Ironshore Pharmaceuticals Inc. | 5 | $114 |
| Vanda Pharmaceuticals Inc. | 5 | $99 |
| Corium, LLC | 3 | $63 |
| GSK | 2 | $49 |
| Almatica Pharma LLC | 2 | $34 |
| Tris Pharma Inc | 2 | $34 |
| Neuronetics, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Boehringer Ingelheim | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$480
- ARISTADA$463
- INGREZZA$232
- CAPLYTA$130
- Ozempic$119
- ARISTADA INITIO$116
- Austedo XR$101
How this compares
$6,088 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 170 | $200,383 |
| LybalviOlanzapine/Samidorphan Malate | 21 | $61,403 |
| VraylarCariprazine Hcl | 34 | $46,114 |
| Invega SustennaPaliperidone Palmitate | 11 | $34,226 |
| CaplytaLumateperone Tosylate | 14 | $20,803 |
| Risperdal ConstaRisperidone Microspheres | 11 | $17,394 |
| Aripiprazole OdtAripiprazole | 18 | $6,305 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,077 |
| Paliperidone ErPaliperidone | 18 | $5,832 |
| Aripiprazole | 79 | $5,202 |
| Haloperidol | 117 | $4,689 |
| Olanzapine | 178 | $4,269 |
| Risperidone OdtRisperidone | 51 | $3,648 |
| Quetiapine Fumarate | 349 | $3,504 |
| Risperidone | 242 | $3,279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $522 | $200,383170 claims |
| Alkermes, Inc.Lybalvi | $1,102 | $61,40321 claims |
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $450 | $51,62022 claims |
| AbbVieVraylar | $395 | $46,11434 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $766 | $20,80314 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $125 | $6,07712 claims |
| Almatica Pharma LLCSertraline Hcl | $34 | $921105 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Compton
- Dalana GonzalezCompton$12K
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.